KRAS and familial pancreatic carcinoma: Furthermore, some overexpressed enzymes upregulated by KRAS, such as RPIA, remain unchanged in some pancreatic cancer cell lines with KRAS deletion to maintain non-oxidative pentose phosphate pathway (PPP) and cancer cell survival via a KRAS-independent pathway (13).